Financials Archives - Page 4 of 40

KEC – KEC International – Q4 FY26 Earnings Call – 18-May-26

KEC International’s topline growth (12–15%) is underpinned by T&D and Civil, but margins (3.6% PBT, 2.6% PAT) and cash flows hinge on West Asia stabilization, steel pass-throughs, and labor normalization.

1–2 minutes

Also see: KEC – KEC International – Q4 FY26 Financial Results – 16-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

West Asia partial normalization by Q2 FY27; INR200–250 cr Q4 revenue spillover recovered. Steel prices oscillate at INR3,000–4,000/tonne, with 50% pass-through success. Civil grows 30%, T&D order intake at INR17,000–18,000 cr, and margins flat to +20bps. EPS growth: 10–12%.

HINDALCO – Hindalco Industries – Q4 FY26 Earnings Call – 22-May-26

HINDALCO’s topline leveraged to aluminum/copper prices and premiums; bottomline sensitive to exceptional items (Oswego, TC/RCs) and cost inflation; margins hinge on operational efficiencies (Novelis cost cuts, captive coal) and regional premiums.

1–2 minutes

Also see: HINDALCO – Hindalco Industries – Q4 FY26 Financial Results – 22-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Aluminum market rebalances in H2 CY26 as European/West Asia restarts and Indonesia ramp-ups offset disruptions. LME averages $2,800–3,000/ton, Midwest premiums normalize to $300–350/ton, and sulfuric acid prices correct in H2 FY27. Bay Minette ramp-up proceeds as planned, captive coal contributes modestly in FY28, and cost inflation stabilizes at ~3–5%. Consolidated EBITDA grows 8–10% in FY27, with net debt-to-EBITDA ~1.9x.

GRASIM – Grasim Industries – Q4 FY26 Earnings Call – 20-May-26

GRASIM’s topline growth hinges on paints/B2B scale-up and macro stability; bottomline/margins depend on raw material cost pass-through and operating leverage in new businesses.

1–2 minutes

Also see: GRASIM – Grasim Industries – Q4 FY26 Financial Results – 20-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Global raw material prices stabilize by H2 FY27; price hikes stick (2–6% + Q1 FY27 increases). Paints market share gains continue (90bps+ QoQ), throughput improves with dealer maturation. B2B e-commerce hits EBITDA break-even by FY27 end. Revenue: INR 1,90,000–2,00,000 crore (FY27), EBITDA margins expand via scale and cost levers.

POWERGRID – Power Grid Corporation – Q4 FY26 Earnings Call – 18-May-26

Power Grid Corporation’s topline growth is structurally robust (₹15 lakh crore+ opportunity), but bottomline and margins hinge on execution pace (CapEx → capitalization conversion) and cost mitigation (RoW, supply chain, IRR protection).

1–2 minutes

Also see: POWERGRID – Power Grid Corporation – Q4 FY26 Financial Results – 15-May-26

3-Scenario Framework

📊 Base Case (60% Probability)

CapEx sustains at ₹40,000–45,000 crore/year (FY27–FY29) with ₹30,000–35,000 crore capitalization, driven by TBCB pipeline execution (₹1.1 lakh crore bidding) and HVDC rollouts (2–3/year). RoW and supply chain bottlenecks ease via market rate mechanisms and OEM expansions. PAT grows 8–10% CAGR (FY26–FY29) on capitalization tailwinds; margins stable (~25% EBITDA) as cost inflation offset by change-in-law claims. ESG leadership and global PPPs add 5–10% to valuation premium.

POWERINDIA – Hitachi Energy India – Q4 FY26 Financial Results – 25-May-26

Hitachi Energy India’s FY26 delivered 810 bps EBITDA margin expansion on scaling revenue, record ₹29,555 Cr backlog, and debt‑free balance sheet — a structural re‑rating story. Risks: WC intensity from receivables/inventory, geopolitical input costs, and execution on ballooning portfolio. Margin inflection with backlog momentum anchors compounding thesis.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 27.6% YoY (₹6,384.9 Cr → ₹8,147.7 Cr), driven by strong execution across grid, data centre, and export orders.
Q4FY26 revenue of ₹2,754 Cr surged 46.2% YoY vs Q4FY25’s ₹1,883.7 Cr — indicating an accelerating exit run-rate.
Order backlog of ₹29,555 Cr (3.6x FY26 revenue) provides multi-year revenue visibility.

Bottomline

PAT jumped 157.2% YoY (₹384 Cr → ₹987.8 Cr); excluding the ₹54.2 Cr exceptional Labour Codes charge, underlying PBT growth is even sharper at 178% (₹516.4 Cr → ₹1,375.2 Cr).
Q4FY26 PAT of ₹330.5 Cr grew 79.7% YoY vs Q4FY25’s ₹183.9 Cr — bottomline acceleration is outpacing topline.
EPS nearly tripled YoY: ₹90.4 → ₹221.6 (basic), on an unchanged share count of 4.46 Cr shares.

Margins

EBITDA (PBT before exceptional + D&A + Finance costs): FY26 = ₹1,375.2 + ₹104.3 + ₹12.8 = ₹1,492.3 Cr; EBITDA margin = 18.3% vs FY25’s (₹516.4 + ₹91.4 + ₹45.2) / ₹6,384.9 = 10.2%. A 810 bps expansion.
Net profit margin: 12.1% in FY26 vs 6.0% in FY25 — a 610 bps improvement, confirming operating leverage is kicking in at scale.
Other income of ₹239.9 Cr (vs ₹57.2 Cr prior year) — largely interest income on the large cash pile — contributed meaningfully; strip this out and core operating margin improvement is still substantial.

Growth Trajectory

Revenue CAGR implied over one year is 27.6%; with Q4 alone clocking ₹2,754 Cr, annualised exit rate is ~₹11,000 Cr — suggesting FY27 consensus could see significant upgrades.
Order intake of ₹18,456.5 Cr in FY26 is 2.3x FY26 revenue — book-to-bill well above 2x, sustaining the growth flywheel.
Exports at 36.8% of Q4 order intake and geographic diversification (US, Europe, APAC) reduce India-concentration risk.

TECHNOE – Techno Electric & Engineering Company – Q4 FY26 Financial Results – 25-May-26

Techno Electric’s FY26 delivered strong topline scaling but margin compression and negative OCF reflect mid‑cycle project execution. Near‑debt‑free balance sheet and ₹22,500 Mn liquidity cushion mitigate stress. Re‑rating hinges on margin inflection — collections, billing cycles, and EBITDA recovery toward 21–22% as projects near completion.

1–2 minutes

🔍 Observations

Topline

Revenue surged 43.3% YoY (₹22,687 Mn → ₹32,516 Mn), reflecting strong EPC order execution acceleration in H2FY26.
Q4FY26 revenue of ₹10,100 Mn grew 23.8% YoY and 15.8% QoQ — execution velocity clearly stepped up into year-end.
Other income declined to ₹1,495 Mn from ₹1,600 Mn as the investment portfolio was partially liquidated to fund working capital.

Bottomline

PAT from continuing operations rose 18.7% YoY (₹3,781 Mn → ₹4,487 Mn), but lagged revenue growth significantly — a margin compression story.
EPS grew only 9.5% YoY (₹37.19 → ₹40.74 on total operations), dampened by the absence of discontinued-ops contribution in FY26 vs FY25.
Q4FY26 PAT of ₹1,145 Mn fell 14.9% YoY vs Q4FY25’s ₹1,346 Mn — lower base quarter profitability despite higher revenues.

Margins

EBITDA margin contracted ~320 bps YoY: 22.0% (FY25) → 18.8% (FY26), as materials cost scaled faster than revenue.
PAT margin (continuing ops) compressed from 16.7% to 13.8% — cost of materials consumed rose to 78.7% of revenue vs 76.8% in FY25.
Finance costs jumped 82.9% (₹105 Mn → ₹193 Mn) as short-term borrowings were deployed to bridge working capital gaps.

Growth Trajectory

Revenue CAGR is strong, but profit growth is decelerating — PAT grew 18.7% on a 43.3% revenue base, signalling margin dilution risk if mix or pricing doesn’t improve.
Discontinued operations contributed ₹282 Mn in FY26 vs ₹448 Mn in FY25 — a structurally fading tailwind.
Order execution is clearly scaling; the question is whether margin recovery follows as projects mature.

RVNL – Rail Vikas Nigam – Q4 FY26 Financial Results – 25-May-26

RVNL’s FY26 shows earnings quality deterioration — topline flat, PAT down a third, and receivables surge turning cash‑generative EPC into cash consumer. Core railway pipeline intact, but re‑rating hinges on FY27 receivables recovery and margin inflection; until OCF turns positive, stock trades on order book narrative.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew a modest 2.5% YoY (₹19,923 Cr → ₹20,412 Cr), signalling execution pace rather than order-book constraints
Q4FY26 revenue of ₹6,696 Cr was the strongest quarter of the year, up 4.2% vs Q4FY25 — typical year-end project billings spike
Other income fell sharply 22.5% YoY (₹1,000 Cr → ₹775 Cr), dragging total income growth below operating revenue growth

Bottomline

Net profit collapsed 31.9% YoY (₹1,278 Cr → ₹871 Cr); EPS fell from ₹6.13 to ₹4.20
Q4FY26 PAT of ₹182 Cr was the weakest quarter — 60% below Q4FY25’s ₹455 Cr — a severe sequential and YoY deterioration
Tax rate improved marginally (22.4% vs 22.4% prior year), ruling out tax as the driver; the damage is entirely operational

Margins

Operating expense ratio (expense of operations / revenue from operations): FY26 = 92.8% vs FY25 = 92.5% — minimal worsening but leaves thin headroom
PBT margin compressed sharply: 5.8% in FY26 vs 8.3% in FY25 (₹1,181 Cr on ₹20,412 Cr revenue vs ₹1,646 Cr on ₹19,923 Cr)
Finance costs declined 23.1% YoY (₹545 Cr → ₹419 Cr) — the one material positive in the cost structure

Growth Trajectory

Revenue CAGR is decelerating; 2.5% topline growth on a government-capex-driven EPC business points to execution or award-conversion bottlenecks
Other income, which contributed ~5% of FY25 PBT, is structurally shrinking as cash balances are deployed or paid out as dividends
JV/associate profit share held flat at ~₹92–94 Cr — no meaningful delta from the equity investment portfolio

BOSCHLTD – Bosch Limited – Q4 FY26 Earnings Call – 21-May-26

Bosch’s findings imply topline resilience (8–10% base-case growth) with margin expansion (50bps) hinging on cost controls and content per vehicle, while PAT growth (10–12%) is anchored by structural initiatives but vulnerable to macro shocks.

1–2 minutes

Also see: BOSCHLTD – Bosch Limited – Q4 FY26 Financial Results – 20-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Macro stability persists; crude oil rises 10%, but supply chain agility offsets costs. Flattish volume growth is offset by content per vehicle gains (CAFE Phase 3, ADAS). JV ramps up in FY’28, contributing 2–3% to revenue. Revenue grows 8–10%, EBITDA margins expand 50bps, and PAT grows 10–12%.

ZYDUSLIFE – Zydus Lifesciences – Q4 FY26 Earnings Call – 19-May-26

Zydus Lifesciences’ topline growth hinges on specialty scaling and international momentum, while margins and cash flow are sensitive to US generics competition, acquisition execution, and capex intensity.

1–2 minutes

Also see: ZYDUSLIFE – Zydus Lifesciences – Q4 FY26 Financial Results – 19-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Management delivers on high-teens revenue growth and >24% EBITDA margins in FY27. US generics decline offset by specialty/international growth, while MedTech/Comfort Click meet guidance. Capex/working capital pressure limits FCF growth, but leverage remains <1x net debt-to-EBITDA. Biosimilar scale-up aligns with FY29–30 timeline.

DIVISLAB – Divi’s Laboratories – Q4 FY26 Financial Results – 23-May-26

Divi’s FY26 delivered topline growth with rare margin expansion in APIs, funded capex doubling via accruals on debt‑free balance sheet. Risks: ₹718 Cr inventory build — demand vs procurement clarity due H1FY27. Strong OCF, accelerating exit rate, and expanding margins keep structural case intact despite FCF compression.

1–2 minutes

🔍 Observations

Topline

Revenue from operations grew 12.8% YoY (₹9,360 Cr → ₹10,560 Cr), with Q4FY26 at ₹2,831 Cr — the strongest quarter of FY26, up 9.5% over Q4FY25’s ₹2,585 Cr.
Sequential revenue momentum held: Q2→Q3→Q4 progression of ₹2,604 Cr → ₹2,604 Cr → ₹2,831 Cr signals an accelerating exit rate into FY27.
Other income jumped 44% YoY (₹352 Cr → ₹507 Cr), driven by interest on FDs; operationally irrelevant but flatters total income.

Bottomline

Net profit grew 17.2% YoY (₹2,191 Cr → ₹2,568 Cr), outpacing revenue — positive operating leverage at work.
Q4FY26 PAT of ₹751 Cr was the highest quarterly print, up 13.4% over Q4FY25’s ₹662 Cr; sequential jump from ₹583 Cr reflects Q3’s one-time labour code charge of ₹74 Cr normalising out.
Basic EPS expanded from ₹82.53 to ₹96.75 — a 17.2% YoY improvement on an unchanged share count.

Margins

EBITDA (PBT ex-other income + depreciation + finance costs): FY26 = ₹3,462 – ₹507 + ₹463 + ₹23 = ₹3,441 Cr on revenue of ₹10,560 Cr → EBITDA margin 32.6% vs FY25: ₹2,916 – ₹352 + ₹402 + ₹2 = ₹2,968 Cr on ₹9,360 Cr → 31.7%. ~90 bps expansion YoY.
Net profit margin (PAT/Revenue from ops): FY26 = 2,568/10,560 = 24.3% vs FY25 = 2,191/9,360 = 23.4%. ~90 bps improvement.
Employee costs grew 16% YoY (₹1,243 Cr → ₹1,442 Cr) and material costs grew 14.6% (₹3,821 Cr → ₹4,378 Cr net of inventory change: ₹3,821–96 = ₹3,725 Cr FY25 vs ₹4,378–285 = ₹4,093 Cr FY26, +9.9%) — cost discipline preserved margin expansion.

Growth Trajectory

Revenue CAGR trajectory: 12.8% in FY26; combined with margin expansion, the earnings growth of 17.2% YoY demonstrates operating leverage materialising at scale.
CWIP nearly doubled (₹1,022 Cr → ₹2,113 Cr) and capex was ₹2,520 Cr in FY26 vs ₹1,438 Cr in FY25 — a 75% capex step-up signals management’s confidence in sustaining double-digit volume growth.
Total equity grew from ₹14,969 Cr to ₹16,761 Cr, entirely through retained earnings; the asset base expanded from ₹16,932 Cr to ₹20,033 Cr — 18.3% in one year.